NCT06979310

Brief Summary

This study is being conducted to determine how best to educate caregivers about cancer and its treatment. When caregivers are well-informed, they are more confident in supporting their child through treatment, which can improve treatment adherence.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
27mo left

Started Jun 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 18, 2025

Completed
1 year until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2028

Last Updated

May 6, 2026

Status Verified

May 1, 2026

Enrollment Period

2.3 years

First QC Date

May 16, 2025

Last Update Submit

May 5, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Treatment abandonment rate.

    All analyses estimating efficacy of the intervention will be based on intention-to-treat principles, whereby participants will be analyzed according to their randomization assignment, irrespective of whether they complied with the intervention.

    6 months

Secondary Outcomes (4)

  • Caregiver knowledge

    Baseline, 6 months

  • Caregiver attitudes

    Baseline, 6 months

  • Perceived behavior control

    Baseline, 6 months

  • Caregiver intention

    Baseline, 6 months

Study Arms (4)

text-based education messages only

ACTIVE COMPARATOR
Other: text-based education messages only

in-clinic tablet-based multimedia education only

ACTIVE COMPARATOR
Other: in-clinic tablet-based multimedia education

both text-based and tablet-based digital education strategies

ACTIVE COMPARATOR
Other: text-based education messages onlyOther: in-clinic tablet-based multimedia education

standard of care provider led education

ACTIVE COMPARATOR
Other: standard of care provider led education

Interventions

Participants will receive tablet-based multimedia education in clinic

both text-based and tablet-based digital education strategiesin-clinic tablet-based multimedia education only

Participants will receive standard of care education from their provider

standard of care provider led education

Participants will receive text-based education messages

both text-based and tablet-based digital education strategiestext-based education messages only

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • a known pediatric cancer diagnosis
  • Adult caregivers of children with cancer (\<18yo) at time of new patient registration
  • Ability to understand and speak Swahili
  • If illiterate, availability of a household member who can read Swahili
  • Be able to access the messages

You may not qualify if:

  • any potential participant who is unable to access messages will also be excluded.
  • Non cancer pediatric diagnosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Kristin Schroeder Principal Investigator

    Duke University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hillary Sued Study Coordinator

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2025

First Posted

May 18, 2025

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

August 31, 2028

Study Completion (Estimated)

August 31, 2028

Last Updated

May 6, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

All enrolled participants will be assigned a study identification number (ID) to help protect their identity during data collection and analysis. Only study IDs will be used to identify participants' medical record data, survey and interview responses.